10% Discount
•
CODE: Perlancia10
•
Third-Party Tested Research Peptides
Perlancia Peptides
Perlancia Peptides restricts purchases to individuals conducting laboratory or institutional research and at least 21 years old. By entering, you confirm you meet this requirement.
All products offered on this website are sold strictly as research chemicals for in-vitro laboratory research use only. They are not drugs, foods, cosmetics, dietary supplements or medical devices, and they are not intended for human or veterinary consumption, diagnostic use, or therapeutic use of any kind.
Selecting “No” will take you away from this website. This confirmation will be remembered on this device for 30 days.
$139.00
Tirzepatide is a synthetic peptide analog that has been investigated in metabolic and endocrine research for its interaction with incretin related signaling pathways. Structurally designed to engage both glucose dependent insulinotropic polypeptide (GIP) and glucagon like peptide 1 (GLP-1) receptor systems, tirzepatide has become an area of interest in laboratory studies exploring metabolic regulation mechanisms.
In research environments, tirzepatide is examined for its interaction with signaling networks involved in glucose regulation, endocrine communication, and metabolic pathway modulation. Due to its dual receptor activity, the peptide has attracted attention in studies analyzing multi pathway metabolic signaling.
This product is supplied as a lyophilized research peptide intended for laboratory and analytical applications.
Tirzepatide has been investigated in several laboratory research contexts related to endocrine signaling and metabolic pathway activity.
Common research areas include:
These research areas focus on understanding how peptide hormones interact with receptor networks that influence metabolic signaling processes.
Research has investigated tirzepatide for its interaction with incretin related receptor systems that influence endocrine signaling pathways.
Studies have explored its interaction with:
Laboratory models have examined how dual receptor engagement may influence signaling coordination between multiple metabolic pathways.
Tirzepatide was developed through peptide engineering approaches designed to create compounds capable of interacting with multiple incretin receptor systems. Early research focused on understanding how peptide analogs could engage GLP-1 related signaling pathways, which are involved in endocrine communication related to nutrient sensing.
Subsequent research explored the addition of GIP receptor activity to create dual pathway peptides capable of interacting with more than one incretin signaling mechanism.
Scientific literature has since examined tirzepatide within laboratory models to better understand:
These investigations continue to contribute to broader research into peptide hormone signaling systems.
For laboratory stability, this peptide should be stored in a controlled refrigerated environment after reconstitution.
Proper laboratory storage practices should be followed to maintain compound stability and integrity during research applications.
FOR RESEARCH USE ONLY.
This product is intended strictly for laboratory research purposes. It is not intended for human or veterinary use.
Tirzepatide is part of a class of engineered peptide analogs developed to investigate incretin hormone signaling mechanisms. Incretins are peptide hormones that play roles in endocrine communication associated with nutrient sensing and metabolic regulation.
Native incretin hormones such as GLP-1 and GIP are produced in the gastrointestinal system and participate in signaling pathways that coordinate metabolic responses following nutrient intake.
Researchers have explored synthetic peptide analogs capable of interacting with these receptor systems to better understand how dual receptor signaling may influence metabolic regulatory pathways.
Tirzepatide was developed as a dual receptor peptide capable of engaging both GLP-1 and GIP receptors, making it a subject of interest in metabolic signaling research.
Laboratory studies have examined tirzepatide within experimental models investigating metabolic signaling pathways that regulate endocrine communication related to nutrient sensing.
Researchers have studied tirzepatide for its interaction with incretin receptors, particularly GLP-1 and GIP receptor systems, which participate in peptide hormone signaling networks.
Research has explored how dual receptor peptide analogs influence signaling coordination between hormone regulated pathways involved in metabolic processes.
Laboratory models have also investigated how incretin receptor engagement may influence cellular signaling mechanisms related to energy regulation and endocrine communication.
Research has examined tirzepatide for its interaction with incretin receptor signaling pathways that contribute to metabolic regulatory networks.
Studies have explored its interaction with:
These research areas aim to better understand how peptide analogs may interact with multiple receptor systems within complex metabolic signaling environments.
Scientific literature investigating incretin related peptides has explored how GLP-1 and GIP receptor signaling pathways participate in endocrine communication related to metabolic regulation.
Research examining dual receptor peptides such as tirzepatide has contributed to broader understanding of how peptide hormones coordinate signaling across multiple receptor systems.
Laboratory investigations continue to explore receptor binding characteristics, signaling cascades, and pathway interactions associated with incretin related peptides.
Researchers studying tirzepatide and related incretin peptides frequently reference literature available through sources such as:
Researchers seeking additional information may consult scientific literature databases and academic publications for further details regarding peptide signaling research.
| MG | 15MG, 30 MG |
|---|
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
Tirzepatide is a synthetic peptide analog that has been investigated in metabolic and endocrine research for its interaction with incretin related signaling pathways. Structurally designed to engage both glucose dependent insulinotropic polypeptide (GIP) and glucagon like peptide 1 (GLP-1) receptor systems, tirzepatide has become an area of interest in laboratory studies exploring metabolic regulation mechanisms.
In research environments, tirzepatide is examined for its interaction with signaling networks involved in glucose regulation, endocrine communication, and metabolic pathway modulation. Due to its dual receptor activity, the peptide has attracted attention in studies analyzing multi pathway metabolic signaling.
This product is supplied as a lyophilized research peptide intended for laboratory and analytical applications.
Tirzepatide has been investigated in several laboratory research contexts related to endocrine signaling and metabolic pathway activity.
Common research areas include:
These research areas focus on understanding how peptide hormones interact with receptor networks that influence metabolic signaling processes.
Research has investigated tirzepatide for its interaction with incretin related receptor systems that influence endocrine signaling pathways.
Studies have explored its interaction with:
Laboratory models have examined how dual receptor engagement may influence signaling coordination between multiple metabolic pathways.
Tirzepatide was developed through peptide engineering approaches designed to create compounds capable of interacting with multiple incretin receptor systems. Early research focused on understanding how peptide analogs could engage GLP-1 related signaling pathways, which are involved in endocrine communication related to nutrient sensing.
Subsequent research explored the addition of GIP receptor activity to create dual pathway peptides capable of interacting with more than one incretin signaling mechanism.
Scientific literature has since examined tirzepatide within laboratory models to better understand:
These investigations continue to contribute to broader research into peptide hormone signaling systems.
For laboratory stability, this peptide should be stored in a controlled refrigerated environment after reconstitution.
Proper laboratory storage practices should be followed to maintain compound stability and integrity during research applications.
FOR RESEARCH USE ONLY.
This product is intended strictly for laboratory research purposes. It is not intended for human or veterinary use.
Tirzepatide is part of a class of engineered peptide analogs developed to investigate incretin hormone signaling mechanisms. Incretins are peptide hormones that play roles in endocrine communication associated with nutrient sensing and metabolic regulation.
Native incretin hormones such as GLP-1 and GIP are produced in the gastrointestinal system and participate in signaling pathways that coordinate metabolic responses following nutrient intake.
Researchers have explored synthetic peptide analogs capable of interacting with these receptor systems to better understand how dual receptor signaling may influence metabolic regulatory pathways.
Tirzepatide was developed as a dual receptor peptide capable of engaging both GLP-1 and GIP receptors, making it a subject of interest in metabolic signaling research.
Laboratory studies have examined tirzepatide within experimental models investigating metabolic signaling pathways that regulate endocrine communication related to nutrient sensing.
Researchers have studied tirzepatide for its interaction with incretin receptors, particularly GLP-1 and GIP receptor systems, which participate in peptide hormone signaling networks.
Research has explored how dual receptor peptide analogs influence signaling coordination between hormone regulated pathways involved in metabolic processes.
Laboratory models have also investigated how incretin receptor engagement may influence cellular signaling mechanisms related to energy regulation and endocrine communication.
Research has examined tirzepatide for its interaction with incretin receptor signaling pathways that contribute to metabolic regulatory networks.
Studies have explored its interaction with:
These research areas aim to better understand how peptide analogs may interact with multiple receptor systems within complex metabolic signaling environments.
Scientific literature investigating incretin related peptides has explored how GLP-1 and GIP receptor signaling pathways participate in endocrine communication related to metabolic regulation.
Research examining dual receptor peptides such as tirzepatide has contributed to broader understanding of how peptide hormones coordinate signaling across multiple receptor systems.
Laboratory investigations continue to explore receptor binding characteristics, signaling cascades, and pathway interactions associated with incretin related peptides.
Researchers studying tirzepatide and related incretin peptides frequently reference literature available through sources such as:
Researchers seeking additional information may consult scientific literature databases and academic publications for further details regarding peptide signaling research.
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.